Neurotoxicity refers to adverse effects on the human brain or nervous system caused by chemical, physical or environmental factors. Researchers have long established links between neurotoxicity and exposure to some commonly used drugs and chemicals.
FDA Modernization Act
The FDA Modernization Act is the latest addendum to a comprehensive set of consumer health-related laws that have been in place for over a century, beginning with the Pure Food and Drug Act of 1906. This landmark piece of legislation was designed to protect consumers from mislabeled or dangerous food and medicine, at a time when there was little to no regulation in either industry.
CELLvo™ ChondroMatrix for Cell-Based Articular Cartilage Therapy
Articular cartilage is the elastic tissue that covers the end of a bone at its joint; it provides cushioning and allows for frictionless motion between bones. Unfortunately, articular cartilage is prone to damage, either through injury or age- and usage-based degeneration. This damage progresses over time, eventually leading to osteoarthritis of the joint.
CELLvo™ Matrix Plus: Shaping the Future of In Vitro Cardiomyocyte Culture
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) possess outstanding potential for use in cardiotoxicity assays as part of pre-clinical drug discovery. Specifically, these cardiomyocytes can be utilized to detect drug-induced proarrhythmia, thereby enabling scientists and medical professionals to evaluate the risk of heart rhythm disturbances from various drugs under development. The Comprehensive In Vitro Proarrhythmia Assay (CiPA) initiative was created by the FDA and the drug discovery field to build on this finding.
CELLvo™ Matrix Technology: Making Cell Culture Relevant
Endothelial Progenitor Cells in Human Cord Blood
Empower Your Chondrocyte Research
Introducing CELLvo™ Human Chondrocytes and CELLvo™ Matrix, a New Culture System
Young, healthy cells at early passage, or older, uncultured osteoarthritic cells – your choice. We offer the means for a deeper understanding of authentic chondrocyte behavior.
Broaden your knowledge by comparing healthy and diseased chondrocytes, or expand chondrocyte cultures while maintaining potency and natural phenotype with reduced dedifferentiation.
When you grow CELLvo™ Human Chondrocyte cells on CELLvo™ Matrix, you have the ability to truly empower your research.
Creating a Natural Microenvironment for Culturing Islet Cells
Opening the door to predictive cardiac toxicity testing…
StemBioSys Scientist shares her story with the Texas Public Radio audience
StemBioSys Scientist, Anne Sheldrake, was invited to speak at Texas Public Radio’s first “Worth Repeating” event of their 5th season. She shared her story of confronting a mental health issue while pursuing a PhD. It is important to share these stories in the biosciences industry as graduate student mental health is too often ignored. Anne confronted and overcame an eating disorder, and for the last 2 years has been a key driver of innovation and new product development at StemBioSys. Anne, thank you for sharing your story.